Pascual A, Joyanes P, Martinez-Martinez L, Suarez A I, Perea E J
Department of Microbiology, School of Medicine, University of Seville, Spain.
J Clin Microbiol. 1996 Mar;34(3):588-91. doi: 10.1128/jcm.34.3.588-591.1996.
The susceptibilities of 54 clinical isolates of Neisseria meningitidis to penicillin, cefotaxime, ceftriaxone, cefepime, imipenem, ciprofloxacin, chloramphenicol, and rifampin were determined by the microdilution method in both cation-adjusted Mueller-Hinton broth (CAMHB) and Haemophilus test medium (HTM). Poor growth was observed in 16.6 and 9% of the strains in CAMHB and HTM, respectively. As a result, the growth of the 54 N. meningitidis strains was evaluated in three other commercially available batches of CAMHB and in one in-house batch of HTM. Poor growth was observed for 9.3 to 16.6% of the strains in all four batches. More important, three of the CAMHB batches failed to support growth for 3.7 to 33.3% of the strains; 3.7% of the strains did not grow in the in-house-prepared HTM. Ten (18.7%) strains were relatively resistant to penicillin (RRP; MIC, > 0.125 mu g/ml) in CAMHB and 13 (24%) strains were RRP in HTM. The percentages of agreement obtained by using CAMHB as the reference ranged from 78% for cefepime to 100% for ceftriaxone. Seven minor errors were observed for penicillin; five of them were for strains susceptible to penicillin in CAMHB and RRP in HTM. All strains were susceptible to the other antimicrobial agents evaluated. The growth of N. meningitidis was also evaluated in four batches of Mueller-Hinton agar (MHA). In two of them, 3.7 and 44.4% of the strains did not grow, and considering all four batches, 5.5 to 11.1% grew poorly. All strains grew adequately in MHA supplemented with blood (MHA-b). The activities of penicillin and cefotaxime were also evaluated by the E-test in MHA and MHA-b. The proportion of RRP strains were 24% in MHA and 59% in MHA-b. For penicillin, the percentages of agreement of the E-test with the microdilution method in CAMHB (reference) were 64.8 and 70.3% in MHA and MHA-b, respectively. For cefotaxime, the agreement was 98.1%. Minor errors for the penicillin MIC were detected for 38% of the strains tested. Further studies are needed to define adequate culture media for reference methods to evaluate the susceptibility of N. meningitidis to antimicrobial agents.
采用微量稀释法,在阳离子调节的 Mueller-Hinton 肉汤(CAMHB)和嗜血杆菌检测培养基(HTM)中,测定了 54 株脑膜炎奈瑟菌临床分离株对青霉素、头孢噻肟、头孢曲松、头孢吡肟、亚胺培南、环丙沙星、氯霉素和利福平的敏感性。分别在 CAMHB 和 HTM 中观察到 16.6%和 9%的菌株生长不佳。因此,对 54 株脑膜炎奈瑟菌在另外三个市售批次的 CAMHB 和一个自制批次的 HTM 中的生长情况进行了评估。在所有四个批次中,观察到 9.3%至 16.6%的菌株生长不佳。更重要的是,三个 CAMHB 批次不能支持 3.7%至 33.3%的菌株生长;3.7%的菌株在自制的 HTM 中不生长。在 CAMHB 中,有 10 株(18.7%)菌株对青霉素相对耐药(RRP;MIC,>0.125μg/ml),在 HTM 中有 13 株(24%)菌株为 RRP。以 CAMHB 作为参考,头孢吡肟的一致性百分比为 78%,头孢曲松为 100%。观察到青霉素有 7 个小误差;其中 5 个是针对在 CAMHB 中对青霉素敏感而在 HTM 中为 RRP 的菌株。所有菌株对其他评估的抗菌药物均敏感。还在四批次 Mueller-Hinton 琼脂(MHA)中评估了脑膜炎奈瑟菌的生长情况。其中两批中,分别有 3.7%和 44.4%的菌株不生长,考虑所有四批,5.5%至 11.1%的菌株生长不佳。所有菌株在补充血液的 MHA(MHA-b)中生长良好。还通过 E 试验在 MHA 和 MHA-b 中评估了青霉素和头孢噻肟的活性。RRP 菌株的比例在 MHA 中为 24%,在 MHA-b 中为 59%。对于青霉素,E 试验与 CAMHB(参考)中的微量稀释法的一致性百分比在 MHA 和 MHA-b 中分别为 64.8%和 70.3%。对于头孢噻肟,一致性为 98.1%。在所测试的 38%的菌株中检测到青霉素 MIC 的小误差。需要进一步研究来确定用于评估脑膜炎奈瑟菌对抗菌药物敏感性的参考方法的合适培养基。